𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple extranodal sites at presentation in non-Hodgkin's lymphoma

✍ Scribed by Devinder Singh; Atul Sharma; B.K. Mohanti; Sanjay Thulkar; Sudhir Bahadur; S.C. Sharma; S. Dutta Gupta


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
105 KB
Volume
74
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

About one‐third of NHL patients present lymphomas at extranodal sites. Involvement of multiple noncontiguous extranodal sites at presentation without lymph node involvement is unknown. Herein we present two such cases. The first patient had sinonasal tract and urinary bladder NHL at presentation, while the other patient presented with bilateral adrenal involvement in addition to sinonasal tract NHL. Clinical presentation and pathophysiology are discussed, and a brief review of literature is included. Am. J. Hematol. 74:75–77, 2003. Β© 2003 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Primary renal non-Hodgkin's lymphoma. An
✍ Scott H. Okuno; James D. Hoyer; Kay Ristow; Dr. Thomas E. Witzig πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 369 KB

Background. Primary renal non-Hodgkin's lymphoma (NHL) is rare. Because the renal parenchyma does not have lymphatics, the existence of this entity has been questioned. The goal of this study was to determine the clinical presentation, pathologic features, and disease course of patients with primary

Application of the international prognos
✍ Tony S. Mok; Joyce Steinberg; Anthony T. Chan; Winnie M. Yeo; P. Hui; Thomas W. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 1 views

## Background: Chemotherapy containing anthracycline is the standard initial treatment for aggressive non-hodgkin's lymphoma (nhl), and the international prognostic index (ipi) is widely accepted as the standard tool for determining the prognosis of patients with this disease. however, the data on